*To the Editor*:

We read with interest the report of Breuer and colleagues and note the important finding that *Aspergillus* species were the most frequently isolated pathogens in this preschool cystic fibrosis cohort on annual surveillance bronchoscopies ([@bib1]). This certainly supports previous data suggesting that the prevalence of *Aspergillus* in this age group is likely underestimated by less interventional methods of microbiological screening ([@bib2]). It also aligns with the accumulating evidence that increasing prevalence is associated with increasingly aggressive use of antibiotics in this cohort, and we would support the call for further work to explore the clinical implications of fungal airway infection. We are, however, concerned that the data may not represent the full picture of cystic fibrosis airway microbiology in early childhood, most notably for the omission of microbiology results from airway samples obtained during pulmonary exacerbations.

We acknowledge that previously reported data from the same group report the sensitivity of oropharyngeal (OP) cultures for the detection of *Pseudomonas aeruginosa* to be low (23%) when compared against BAL performed at times of clinical stability ([@bib3]). However, during pulmonary exacerbations, substantially higher sensitivity (76%) is reported for OP cultures compared with BAL for the detection of *P. aeruginosa* ([@bib4]), and no benefit has been found for a strategy of bronchoscopic airway sampling over noninvasive sampling to guide treatment of pulmonary exacerbations in young children ([@bib5]). Although imperfect, noninvasive airway sampling, with reduced exposure to general anesthesia risk and a significantly reduced cost, continues to form a routine part of clinical care in many cystic fibrosis centers worldwide. Sputum induction has also been shown to act as a credible alternative to BAL in symptomatic children ([@bib6]).

In the current study ([@bib1]), routine treatment of pulmonary exacerbations at one of the two study sites was guided by previous cultures (including OP samples), thereby inferring that OP cultures were considered to reflect lower airway microbiology. Yet the results of noninvasive (OP or other) cultures collected between surveillance bronchoscopies, and in particular during pulmonary exacerbations, are not reported. The omission of microbiological samples collected during symptomatic periods risks potential underreporting of the prevalence of bacterial airway infection, particularly if infection is then cleared after targeted antibiotic therapy.
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